Suppressors of cytokine signalling-3 and -1 in human carcinogenesis

10.2741/s372 ◽  
2013 ◽  
Vol S5 (1) ◽  
pp. 277-283 ◽  
Author(s):  
Zoran Culig 
Keyword(s):  
Human Carcinogenesis

Role of FGFs and FGF Receptors in Human Carcinogenesis

1991 ◽  
Vol 638 (1 The Fibroblas) ◽  
pp. 409-411 ◽  
Author(s):  
D. BIRNBAUM ◽  
O. deLAPEYRIERE,a ◽  
J. ADNANE ◽  
C. DIONNE ◽  
G. CRUMLEY ◽  
...  
Keyword(s):  
Human Carcinogenesis

Host factors in human carcinogenesis

1983 ◽  
Vol 31 (1) ◽  
pp. 99-100
Author(s):  
E.I. Hamilton
Keyword(s):  
Host Factors ◽  
Human Carcinogenesis

scholarly journals Human Carcinogenesis: Toward a Unified Theory

OALib ◽  
2017 ◽  
Vol 04 (07) ◽  
pp. 1-14
Author(s):  
Briana Marshall ◽  
Doug Dix
Keyword(s):  
Unified Theory ◽  
Human Carcinogenesis

Molecular mechanisms of human carcinogenesis

2006 ◽  
pp. 321-349 ◽  
Author(s):  
William B. Coleman ◽  
Gregory J. Tsongalis
Keyword(s):  
Molecular Mechanisms ◽  
Human Carcinogenesis

scholarly journals Mismatch repair defects in human carcinogenesis

1996 ◽  
Vol 5 (Supplement_1) ◽  
pp. 1489-1494 ◽  
Author(s):  
James R. Eshleman ◽  
Sanford D. Markowitz
Keyword(s):  
Mismatch Repair ◽  
Human Carcinogenesis

Role of Dehydroepiandrosterone in Experimental and Human Carcinogenesis

2011 ◽  
Author(s):  
Francesco Feo ◽  
Rosa M. Pascale ◽  
Maria M. Simile ◽  
Maria R. De Miglio
Keyword(s):  
Human Carcinogenesis

Relevance of metabolic polymorphisms to human carcinogenesis: evaluation of epidemiologic evidence

1991 ◽  
Vol 1 (1) ◽  
pp. 4-19 ◽  
Author(s):  
Neil Caporaso ◽  
Maria Teresa Landi ◽  
Paolo Vineis
Keyword(s):  
Human Carcinogenesis ◽  
Epidemiologic Evidence

scholarly journals Roles of NOTCH1 as a Therapeutic Target and a Biomarker for Lung Cancer: Controversies and Perspectives

2015 ◽  
Vol 2015 ◽  
pp. 1-8 ◽  
Author(s):  
Lixia Guo ◽  
Ting Zhang ◽  
Ying Xiong ◽  
Yanan Yang
Keyword(s):  
Lung Cancer ◽  
Therapeutic Target ◽  
Early Stage ◽  
Small Population ◽  
Cancer Development ◽  
Potential Usefulness ◽  
Early Stage Lung Cancer ◽  
Human Carcinogenesis ◽  
Stage Lung Cancer

Lung cancer is one of the most common types of human malignancies and the leading cause of cancer-related death. Patients with surgically resectable early stage lung cancer are more likely curable, but currently only a small population of patients can be diagnosed at such a stage, partly due to our incomplete understanding of the biology of lung cancer and the lack of diagnostic and prognostic biomarkers. Recent studies have shown that NOTCH1 is a critical regulator of human carcinogenesis and has been implicated in multiple steps of cancer development and progression. Herein, we review recent findings about the role of NOTCH1 in lung cancer and discuss its potential usefulness as both a therapeutic target and a biomarker for lung cancer.

Sign in / Sign up

Export Citation Format

Share Document